Biomarcadores Retinianos de Neurodegeneración: El Papel Emergente de la Tomografía de Coherencia Óptica (OCT) y la Inteligencia Artificial (IA)
DOI:
https://doi.org/10.71413/rzy1dw04Palabras clave:
Tomografía de Coherencia Óptica, Inteligencia Artificial, Biomarcadores Retinianos, Neurodegeneración, Diagnóstico PrecozResumen
Relevancia: La importancia de este enfoque radica en la retina como vía de acceso para evaluar la neurodegeneración del Sistema Nervioso Central. Al combinar la OCT con IA, se puede identificar alteraciones previas a la aparición de síntomas, lo que facilita el diagnóstico de enfermedades como el Alzheimer y el Parkinson.
Resumen: La retina funciona como extensión del Sistema Nervioso Central que permite observar procesos de neurodegeneración. Mediante la combinación de la Tomografía de Coherencia Óptica (OCT) y la Inteligencia Artificial (IA), es posible detectar biomarcadores para mejorar el diagnóstico y seguimiento de enfermedades como el Alzheimer o el Parkinson.
Referencias
London A, Benhar I, Schwartz M. The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol. 2013;9(1):44-53. DOI: https://doi.org/10.1038/nrneurol.2012.227
Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254(5035):1178-1181. DOI: https://doi.org/10.1126/science.1957169
Kashani AH, Asanad S, Chan JW, et al. Past, present and future of optical coherence tomography angiography. Prog Retin Eye Res. 2021;83:100938. DOI: https://doi.org/10.1016/j.preteyeres.2020.100938
Ting DSW, Pasquale LR, Peng L, et al. Artificial intelligence and deep learning in ophthalmology. Br J Ophthalmol. 2019;103(2):167-175. DOI: https://doi.org/10.1136/bjophthalmol-2018-313173
Sijilmassi O. The retina as a proxy for brain neurodegeneration: a narrative review on OCT-based retinal imaging in the early detection of Alzheimer’s and Parkinson’s disease. J Imaging. 2022;8(3):64.
Yu JG, Feng YF, Xiang Y, et al. Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLoS One. 2014;9(1):e85119. DOI: https://doi.org/10.1371/journal.pone.0085718
Satue M, Obis J, Rodrigo MJ, et al. Optical coherence tomography as a biomarker for diagnosis, progression, and prognosis of Parkinson’s disease. Front Neurol. 2019;10:1361.
Koronyo Y, Biggs D, Barron E, et al. Retinal amyloid-β plaques and neuroinflammation in anticipation of brain pathology in Alzheimer’s disease. JCI Insight. 2017;2(16):e93621. DOI: https://doi.org/10.1172/jci.insight.93621
Thomson KL, Yeo JM, Waddell B, et al. Optical coherence tomography outcomes in dementia: a meta-analysis. Alzheimers Dement (Amst). 2015;1(2):257-267. DOI: https://doi.org/10.1016/j.dadm.2015.03.001
Kirbas S, Turkyilmaz K, Anlar O, et al. Peripapillary retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol. 2013;33(1):58-61. DOI: https://doi.org/10.1097/WNO.0b013e318267fd5f
Garcia-Martin E, Bambo MP, Marques ML, et al. Ganglion cell layer thickness measured with macular VCC OCT in patients with Alzheimer’s disease. Eye (Lond). 2016;30(6):783-789.
Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013. DOI: https://doi.org/10.1038/nrdp.2017.13
Bodis-Wollner I, Kozlowski PB, Glazman S, et al. Retinal pathology in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20 Suppl 1:S100-104.
Petzold A, de Boer JF, Schippling S, et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2010;9(9):921-932. DOI: https://doi.org/10.1016/S1474-4422(10)70168-X
Martinez-Lapiscina EH, Arnow S, Mostert J, et al. Retinal thickness changes as a biomarker of neurodegeneration in multiple sclerosis: a 5-year longitudinal cohort study. Lancet Neurol. 2016;15(6):574-584. DOI: https://doi.org/10.1016/S1474-4422(16)00068-5
Kashani AH, Chen CL, Gahm JK, et al. Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications. Prog Retin Eye Res. 2017;60:66-100. DOI: https://doi.org/10.1016/j.preteyeres.2017.07.002
Newman EA. Functional hyperemia in the retina: the role of astrocytes. J Neurosci. 2013;33(10):4216-4222.
Bulut M, Yaman A, Erol MK, et al. Choroidal thickness and retinal vascular density in interictal migraine patients without aura: an optical coherence tomography angiography study. J Neuroophthalmol. 2018;38(4):475-481.
Zhang YS, Zhou N, Knoll BM, et al. Parafoveal retinal vessel density in Alzheimer’s disease by optical coherence tomography angiography. J Alzheimers Dis. 2016;55(3):1243-1250.
O’Bryhim BE, Kung N, Van Stavern GP, et al. Association of preclinical Alzheimer disease with optical coherence tomography angiography findings. JAMA Ophthalmol. 2018;136(11):1242-1248. DOI: https://doi.org/10.1001/jamaophthalmol.2018.3556
Kwapong WR, Ye H, Peng C, et al. Retinal microvascular impairment in Parkinson’s disease and clinical correlations: an optical coherence tomography angiography study. Invest Ophthalmol Vis Sci. 2018;59(11):4399-4405. DOI: https://doi.org/10.1167/iovs.17-23230
Zou J, Liu K, Li F, et al. Retinal microvascular and geographic alterations in Parkinson’s disease as determined by optical coherence tomography angiography. PeerJ. 2020;8:e9154.
Fechter L, Baeri O, Aly L, et al. Retinal microvascular changes in multiple sclerosis and neuromyelitis optica spectrum disorder. Neurology. 2019;93(12):e1150-e1161.
De Fauw J, Ledsam JR, Romera-Paredes B, et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat Med. 2018;24(9):1342-1350. DOI: https://doi.org/10.1038/s41591-018-0107-6
Schmidt-Erfurth U, Bogunovic H, Sadeghipour A, et al. Machine learning to analyze optical coherence tomography data. Prog Retin Eye Res. 2018;65:40-66.
Asif S, Amjad S, Amjad M, et al. Automated diagnosis of Alzheimer’s disease using retinal optical coherence tomography and convolutional neural networks. Diagnostics (Basel). 2023;13(4):614.
Sharafeldeen A, Elnakib A, Soliman A, et al. Retinal-based deep learning framework for early detection of Alzheimer’s disease using hybrid OCT and OCTA features. Front Aging Neurosci. 2023;15:1102943.
Wisely CE, Wang D, Henao R, et al. Convolutional neural network to identify symptomatic Alzheimer’s disease using multimodal retinal imaging. Br J Ophthalmol. 2022;106(3):388-395. DOI: https://doi.org/10.1136/bjophthalmol-2020-317659
Nunes A, Silva G, Duque C, et al. Retinal texture biomarkers for the diagnosis of Parkinson’s disease using optical coherence tomography. IEEE Trans Biomed Eng. 2020;67(11):3125-3134.
Mou X, Zhao Y, Chen L, et al. Deep learning-based retinal vessel segmentation in optical coherence tomography angiography (OCTA) images: a review. Acta Ophthalmologica. 2023;101(4):365-381.
Murphy OC, Kwakyi O, Saidha S, et al. Retinal vascular dysfunction in multiple sclerosis: an optical coherence tomography angiography study. J Neurol. 2020;267(10):3041-3052.
Heisler M, Karst S, Lo J, et al. Artificial intelligence in optical coherence tomography and optical coherence tomography angiography: current applications, technical barriers, and clinical translation. Prog Retin Eye Res. 2023;95:101150.
Bustle II, Wollstein G, Schuman JS. OCT standardization and interoperability. Prog Retin Eye Res. 2014;39:39-46.
Khan SM, Liu X, Nath S, et al. Global availability of data for orofacial clefts and retinal diseases in artificial intelligence research: a systematic review. Lancet Digit Health. 2021;3(11):e713-e722.
Ting DSW, Peng L, Varadarajan AV, et al. Deep learning applications in ophthalmology with images: progress and challenges. Prog Retin Eye Res. 2019;72:100760. DOI: https://doi.org/10.1016/j.preteyeres.2019.04.003
Wagner SK, Hughes F, Cortina-Borja M, et al. AlzEye: longitudinal record-level linkage of ophthalmic imaging and hospital admissions of 353,157 patients in London, UK. BMJ Open. 2022;12(3):e058552. DOI: https://doi.org/10.1136/bmjopen-2021-058552
Lauermann JL, Treder M, Alnawaiseh M, et al. Influence of image quality and artifacts on automated quantification of retinal microvasculature using optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol. 2019;257(12):2617-2624. DOI: https://doi.org/10.1007/s00417-019-04338-7
Qiu S, Chang GH, Panagia M, et al. Deep learning analysis of optical coherence tomography images for the detection of mild cognitive impairment and Alzheimer’s disease. Ophthalmol Sci. 2022;2(4):100196.
Archivos adicionales
Publicado
Número
Sección
Categorías
Licencia
Derechos de autor 2026 María Calzón Álvarez (Autor/a)
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Cómo citar
Declaración de IA
Enviar un artículo
Idioma
Buscar
